Japanese Researchers: Urgent Action Needed To Address Mass Contamination Of Blood Supply

May 30, 2024 antivax

STORY AT-A-GLANCE

> Japanese researchers warn of the risks of using blood from mRNA COVID vaccine recipients, highlighting potential deadly effects and the need for urgent action to secure the global blood supply

> Blood contaminated with prion-like structures from the spike protein raises the risk of inducing fatal neurodegenerative diseases in recipients. The potential transmission of harmful proteins through exosomes (“shedding”) and the risk of autoimmune diseases due to the vaccines’ mechanism and components like lipid nanoparticles (LNPs) are other major concerns

> Proposals for managing blood collection include rigorous donor interviews, deferral periods, and a suite of tests to ensure the safety of blood products

> The researchers advocate for comprehensive testing of both jabbed and unjabbed individuals to assess the safety of blood products and suggest discarding blood products contaminated with spike proteins or modified mRNA until effective removal methods have been developed

> They call for suspending all gene-based “vaccines” and conducting a rigorous harm-benefit assessment in light of the serious health injuries reported. They also urge countries and organizations to take concrete steps to address and mitigate the already identified risks

In a recent meta-analysis^1,² posted on preprints.org, Japanese researchers warn of potentially deadly risks to patients who receive blood from people who have taken mRNA COVID jabs and call for urgent action to ensure the safety of the global blood supply. According to the authors:³

“… many countries around the world have reported that so-called genetic vaccines, such as those using modified mRNA encoding the spike protein and lipid nanoparticles as the drug delivery system, have resulted in post-vaccination thrombosis and subsequent cardiovascular damage, as well as a wide variety of diseases involving all organs and systems, including the nervous system …

“[B]ased on these circumstances and the volume of evidence that has recently come to light, we call the attention of medical professionals to the various risks associated with blood transfusions using blood products derived from people who have suffered from long COVID and from genetic vaccine recipients, including those who have received mRNA vaccines, and we make proposals regarding specific tests, testing methods, and regulations to deal with these risks.”

Blood From Jabbed Donors May Pose Risk to Neurological Health

One particular risk addressed in this paper is the implications of blood tainted with prion-like structures found within the spike protein. Prions are misfolded proteins that can cause neurodegenerative diseases, such as Creutzfeldt-Jakob Disease (CJD) in humans, by inducing the misfolding of normal proteins in the brain.

Prion diseases are characterized by a long incubation period, followed by rapid progression and high mortality. The suggestion that the spike protein of SARS-CoV-2, especially from certain variants, might contain prion-like domains raises concerns for several reasons:

Transmission risk — If spike proteins with prion-like structures can be transmitted through blood transfusions, there might be a risk of inducing prion diseases in recipients. Prion diseases are notoriously difficult to diagnose early, have no cure, and are fatal, making any potential transmission through blood products a significant safety concern.
Detection and removal challenges — Current blood screening processes do not specifically test for prions, partly because prion diseases are rare and partly due to the technical challenges in detecting prions at low concentrations. If spike proteins with prion-like properties are present in the blood of COVID jabbed individuals, existing blood safety protocols may not be adequate to prevent transmission.
Long-term safety concerns — Prion diseases have long latency periods, meaning that symptoms can appear years or even decades after exposure. This delay complicates efforts to trace the source of an infection back to a blood transfusion and assess the safety of blood supplies over time.